Use of the ligand immunofunctional assay for human insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) to analyze IGFBP-3 proteolysis and IGF-I bioavailability in healthy adults, GH-deficient and acromegalic patients, and diabetics

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 5, 2001, Pages 1942-1952

  Lassarre, Claudine ^a   Duron, Francoise ^b   Binoux, Michel ^a,b  

^a INSERM   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; INSULIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ARTICLE; AUTOREGULATION; BIOAVAILABILITY; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE DETERMINATION; HUMAN; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ACROMEGALY; ADOLESCENT; ADULT; AGED; BIOLOGICAL AVAILABILITY; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; NUTRITIONAL STATUS;

EID: 0035019808     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.5.1942     Document Type: Article

References (40)

1. Baxter RC. 1993 Circulating binding proteins for the insulin-like growth factors. Trends Endocrinology Metab. 4:91-96.
2. Binoux M. 1997 GH, IGFs, IGF binding protein-3 and acid-labile subunit: what is the pecking order? Eur J Endocrinol. 137:605-609.
3. Zapf J, Froesch ER. 1999 Insulin-like growth factor I actions on somatic growth. In: Kostyo JL, ed. Handbook of physiology, Section 7, Vol 5: Hormonal control of growth. Oxford: Oxford University Press; 663-699.
4. Giovannucci E. 1999 Insulin-like growth factor 1 and binding protein-3 and risk of cancer. Horm Res. [Suppl 3] 51:34-41.
5. Yakar S, Liu JL, Stannard B, et al. 1999 Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA. 96:7324-7329.
6. LeRoith D, Butler AA. 1999 Insulin-like growth factors in pediatric health and disease. J Clin Endocrinol Metab. 84:4355-4361.
7. Rajaram S, Baylink DJ, Mohan S. 1997 Insulin-like growth factor binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev. 18:801-831.
8. Lassarre C, Binoux M. 1994 Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma. Endocrinology. 134:1254-1262.
9. Blat C, Villaudy J, Binoux M. 1994 In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J Clin Invest. 93:2286-2290.
10. Lassarre C, Binoux M. 2001 Measurement of intact insulin-like growth factor binding protein-3 in human plasma using a ligand immunofunctional assay. J Clin Endocrinol Metab. 86:1260-1266.
11. Thissen JP, Ketelslegers JM, Underwood LE. 1994 Nutritional regulation of the insulin-like growth factors. Endocr Rev. 15:80-101.
12. Gay E, Seurin D, Babajko S, Doublier S, Cazillis M, Binoux M. 1997 Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: repercussions on reproduction, ante- and perinatal mortality and postnatal growth. Endocrinology. 138:2937-2947.
13. Ou CN, Rognerud C. 1993 Rapid analysis of hemoglobin variants by cation-exchange HPLC. J Chromatogr. 39:820-824.
14. Firth SM, Baxter RC. 1995 The role of glycosylation in the action of IGFBP-3. Prog Growth Factor Res. 6:223-229.
15. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. 1986 Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem. 154:138-143.
16. Corpas E, Harman SM, Blackman MR. 1993 Human growth hormone and human aging. Endocr Rev. 14:20-39.
17. Hilding A, Hall K, Wivall-Helleryd IL, Sǎǎf M, Melin AL, Thorén M. 1999 Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects. J Clin Endocrinol Metab. 84:2013-2019.
18. Bonadonna RC, Defronzo RA. 1992 Glucose metabolism in obesity and type II diabetes. In: Björntorp P, Brodoff BN, eds. Obesity. Philadelphia: JB Lippincott Company; 474-501.
19. Baxter RC, Martin JL. 1986 Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J Clin Invest. 78:1504-1512.
20. Veldhuis JD, Iranmanesh A, Lizarralde G, Urban RJ. 1994 Combined deficits in the somatotropic and gonadotropic axes in healthy older men: an appraisal of neuroendocrine mechanisms by deconvolution analysis. Neurobiol Aging. 15:509-517.
21. Bang P, Brismar K, Rosenfeld RG. 1994 Increased proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex. J Clin Endocrinol Metab. 78:1119-1127.
22. Bereket A, Lang CH, Blethen SL, Fan J, Frost RA, Wilson TA. 1995 Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: possible role for insulin in the regulation of IGFBP-3 protease activity. J Clin Endocrinol Metab. 80:2282-2288.
23. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. 1994 Effect of insulin on hepatic production of insulin-like growth factor binding protein-1 (IGFBP-1), IGFBP-3 and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab. 79:872-878.
24. Simpson HL, Umpleby AM, Russell-Jones DL. 1998 Insulin-like growth factor-I and diabetes. A review. Growth Horm IGF Res. 8:83-95.
25. Federici M, Zucaro L, Porzio O, et al. 1996 Increased expression of the insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of noninsulin-dependent diabetes mellitus subjects. J Clin Invest. 98:2887-2893.
26. Lee PDK, Giudice LC, Conover CA, Powell DR. 1997 Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med. 216:319-357.
27. Hossenlopp P, Segovia B, Lassarre C, Roghani M, Bredon M, Binoux M. 1990 Evidence of enzymatic degradation of insulin-like growth factor binding proteins in the "150 K" complex during pregnancy. J Clin Endocrinol Metab. 71:797-805.
28. Giudice LC, Farrell EM, Pham H, Lamson G, Rosenfeld RG. 1990 Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metab. 71:806-816.
29. Lalou C, Binoux M. 1993 Evidence that limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3) occurs in the normal state outside of the bloodstream. Regul Pept. 48:179-188.
30. Lalou C, Silve C, Rosato R, Segovia B, Binoux M. 1994 Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF binding protein-3 production and proteolysis in human osteosarcoma cells. Endocrinology. 135:2318-2326.
31. Angelloz-Nicoud P, Binoux M. 1995 Autocrine regulation of cell proliferation by the IGF and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). Endocrinology. 136:5485-5492.
32. Russell-Jones DL, Umpleby M. 1996 Protein anabolic action of insulin, growth hormone and insulin-like growth factor I. Eur J Endocrinol. 135:631-642.
33. Paquereau L, Vilarem MJ, Rossi V, Rouayrenc JF, Le Cam A. 1992 Regulation of two rat serine-protease inhibitor gene promoters by somatotropin and glucocorticoids. Eur J Biochem. 209:1053-1061.
34. Warren WC, Munie GE, Glenn KC. 1993 Spi-1: an hepatic serine protease inhibitor regulated by GH and other hormones. Mol Cell Endocrinol. 98:27-32.
35. Skjærbæk C, Kaal A, Møller J, et al. 1998 No effect of growth hormone on serum insulin-like growth factor binding protein-3 proteolysis. Endocrinology. 83:1206-1210.
36. Schneider DJ, Sobel BE. 1991 Augmentation of synthesis of plasminogen activator inhibitor type 1 by Insulin and insulin-like growth factor type 1: implications for vascular disease in hyperinsulinic states. Proc Natl Acad Sci USA. 88:9959-9963.
37. Schneider DJ, Nordt TK, Sobel BE. 1992 Stimulation by proinsulin of expression of plasminogen activator inhibitor type-1 in endothelial cells. Diabetes. 41:890-895.
38. Villafuerte BC, Koop BL, Pao CI, GU L, Birdsong GG, Phillips LS. 1994 Coculture of primary rat hepatocytes and nonparenchymal cells permits expression of insulin-like growth factor binding protein-3 in vitro. Endocrinology. 134:2044-2050.
39. Chin E, Zhou J, Dai J, Baxter RC, Bondy C. 1994 Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex. Endocrinology. 134:2498-2504.
40. McGill J, Schneider DJ, Arfken CL, Lucore CL, Sobel BE. 1994 Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes. 43:104-109.